ZESTRIL - Introduction

ZESTRIL is contraindicated in patients who are hypersensitive to this product and in patients with a history of angioedema related to previous treatment with an ACE inhibitor and in patients with hereditary or idiopathic angioedema.

USE IN PREGNANCY
When used in pregnancy during the second and third trimesters, ACE Inhibitors can cause injury and even death to the developing fetus. When pregnancy is detected, ZESTRIL (lisinopril) should be discontinued as soon as possible. See full Prescribing Information, including WARNINGS, Fetal/Neonatal Morbidity and Mortality.

Evaluation of patients with hypertension, heart failure, or MI should always include assessment of renal function (see DOSAGE AND ADMINISTRATION).




FULL PRESCRIBING INFORMATION • SEARCH


Privacy Statement		Legal Information
This product information is intended for US health care professionals only.
215737 10/03 Copyright ©2003 AstraZeneca Pharmaceuticals LP. All rights reserved.

US Corporate Site